With our extensive expertise in evidence submission for reimbursement in established and emerging markets worldwide, we can assist you by:

  • Creating value presentation slide decks and other tools for use in key account management and interaction/negotiation with national and regional payers
  • Strategically preparing HTA and reimbursement dossiers that support your product by leveraging the value story to persuade payers of reimbursement eligibility
  • Developing country-specific HTA dossiers for submission to reimbursement agencies, including those in North America, Europe, and Australia:
    • Academy of Managed Care Pharmacy (AMCP), USA
    • National Institute for Health and Care Excellence (NICE), UK
    • Canadian Agency for Drugs and Technologies in Health (CADTH), Canada
    • Pharmaceutical Benefits Advisory Committee (PBAC), Australia
    • Federal Joint Committee (G-BA), Germany
    • National Authority for Health (HAS), France
    • Italian Medicines Agency (AIFA), Italy
    • Spanish Agency of Medicines and Medical Devices (AEMPS), Spain
    • Scottish Medicines Consortium (SMC), Scotland
    • All Wales Medicines Strategy Group (AWMSG), Wales
    • National Centre for Pharmacoeconomics (NCPE), Ireland
    • National Authority of Medicines and Health Products (INFARMED), Portugal
    • Medical Products Agency (MPA), Sweden
    • Ministry of Health (MZ) and National Health Fund (NFZ), Poland